VistaGen Therapeutics is focused on applying human pluripotent stem cell technology for drug rescue and cell therapy. The company’s Human Clinical Trials in a Test Tube is a pluripotent stem cell technology platform for predictive toxicology, drug development, and drug rescue. Its drug rescue activities combine this technology with modern medicinal chemistry to generate novel chemical variants of once-promising small-molecule drug candidates. Its small molecule drug candidate, AV-101, is completing phase 1 development for treatment of neuropathic pain. For more information, visit the company’s Web site at: www.vistagen.com

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its ninth annual equity conference at The Hard Rock Hotel in Ft. Lauderdale, FL. Attended by institutional investors from across North America, the event features 135 public company executive teams with an emphasis on healthcare, technology, defense, and new-media / entertainment sectors.

Let us hear your thoughts below: